Make your money go further for just 25p per day

Investors Clinic
PREMIUM

Battle of the booze: how to benefit from a battered market

14/08/2019 · C&C · Molson Coors

The UK alcoholic beverage market is being dragged down by apparent sector-wide challenges. In the US, drinkers are losing their taste for mass-market brands. But could the weakness provide a buying opportunity for one of the sector’s biggest companies, Molson Coors? Or could Irish firm C&C be a more profitable choice for UK investors? Here we assess the investment cases of two well priced companies.

All Investors Clinic articles


Investors Clinic
PREMIUM

Do non-executive directors really add value to smaller quoted companies?

Investors Clinic
PREMIUM

Taylor Wimpey vs Lennar: is there more value in a US housebuilder?

08/08/2019 · Lennar · Taylor Wimpey
Investors Clinic

FAANG results: what are the experts saying?

06/08/2019 · Alphabet · Amazon · Apple · Facebook · Netflix

For access to the top news and insights from the investment world

REGISTER FREE TODAY

Become a Champion Investor for as little as £3.20 per report or get a year's worth of money-making analysis for just £90.

SUBSCRIBE NOW
Investors Clinic

Majestic Wine: a sad exit for this former AIM star

05/08/2019 · Majestic Wine
Investors Clinic
PREMIUM

Burberry vs Ralph Lauren: which fashion firm is the better buy?

30/07/2019 · Burberry
Investors Clinic
PREMIUM

Why India is the new China – but better

29/07/2019
Investors Clinic
PREMIUM

Is Levi Strauss a better investment than the UK’s fashion retailers?

24/07/2019 · Levi Strauss
Investors Clinic
PREMIUM

Foreign exchange: how to invest in the hottest of sectors

Investors Clinic
PREMIUM

Daily Mail vs New York Times: which newspaper makes a better investment?

Investors Clinic
PREMIUM

How are the housebuilders coping with the UK property market?

Investors Clinic
PREMIUM

Dear FCA, it’s time to act

09/07/2019